Status | Study |
Recruiting |
Study Name: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Condition: Gastro-enteropancreatic Neuroendocrine Tumor Pancreatic Cancer Date: 2017-02-02 Interventions: Drug: FOLFIRINOX The FOLFIRINO |
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2013-04-02 Interventions: Drug: temozolomide Given PO |
Recruiting |
Study Name: Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Condition: Pancreatic Alpha Cell Carcinoma Pancreatic Beta Islet Cell Carcinoma Date: 2011-10-04 Interventions: Drug: temozolomide Given PO |
Completed |
Study Name: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. Condition: Carcinoma Carcinoma, Renal Cell Neuroendocrine Tumors Date: 2011-07-19 Interventions: Other: Blood sampling by vena punction. We obtain 10mL blood of the patients. The blood is obtained twic |
Terminated |
Study Name: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Condition: Islet Cell Tumor Date: 2011-06-14 Interventions: Drug: Everolimus Everolimus wa |
Recruiting |
Study Name: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders Condition: Islet Cell Tumor Pancreatic Cancer Date: 2009-01-27 Interventions: Other: medical chart review ba |
Completed |
Study Name: A Study of IMC-A12 in Islet Cell Cancer Condition: Carcinoma Neuroendocrine Tumors Date: 2008-10-27 Interventions: Biological: IMC-A12 (cixutumumab) |
Recruiting |
Study Name: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Date: 2008-08-07 Interventions: Drug: PVA microporous hydrospheres/doxorubicin hydrochloride |
Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Date: 2008-01-25 Interventions: Drug: capecitabine Drug: cisplatin |
Terminated |
Study Name: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Condition: Head and Neck Cancer Islet Cell Tumor Date: 2007-04-25 Interventions: Drug: octreotide acetate |